Measurement properties of the Flu-Like Symptom Index from the Hepatitis Physical Symptom Severity Diary

[1]  G. L’italien,et al.  Review of patient-reported outcome measures in chronic hepatitis C , 2012, Health and Quality of Life Outcomes.

[2]  J. Almeida,et al.  Side Effects of the Therapy With Peginterferon and Ribavirin in Chronic Hepatitis C , 2012, Journal of pharmacy practice.

[3]  Peter J. Richardson,et al.  Gaps in the achievement of effectiveness of HCV treatment in national VA practice. , 2012, Journal of hepatology.

[4]  Megan Oser,et al.  Changes in Depressive Symptoms and Impact on Treatment Course Among Hepatitis C Patients Undergoing Interferon-α and Ribavirin Therapy: A Prospective Evaluation , 2011, The American Journal of Gastroenterology.

[5]  G. L’italien,et al.  PGI25 Chronic Hepatitis C (CHC) Related Flu-like Symptoms; Development of a Patient Report Outcome (PRO) Measure and Results from Pilot Efficacy Studies , 2011 .

[6]  M. Ghany,et al.  An Update on Treatment of Genotype 1 Chronic Hepatitis C Virus Infection: 2011 Practice Guideline by the American Association for the Study of Liver Diseases , 2011, Hepatology.

[7]  A. Hauber,et al.  Patient preferences and assessment of likely adherence to hepatitis C virus treatment , 2011, Journal of viral hepatitis.

[8]  P. Hauser,et al.  Screening for depression in patients with hepatitis C using the Beck Depression Inventory-II: do somatic symptoms compromise validity? , 2011, General hospital psychiatry.

[9]  Patricia Taylor-Young,et al.  The Multidimensional Burden of Hepatitis C and Its Treatment: A Case Study , 2009, Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates.

[10]  M. Ghany,et al.  Diagnosis, management, and treatment of hepatitis C: An update , 2009, Hepatology.

[11]  A. Gifford,et al.  Living with Hepatitis C: Qualitative Interviews with Hepatitis C-infected Veterans , 2008, Journal of general internal medicine.

[12]  L. Fraenkel,et al.  Patients' experiences related to anti-viral treatment for hepatitis C. , 2006, Patient education and counseling.

[13]  M. Alter,et al.  The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002 , 2006, Annals of Internal Medicine.

[14]  S. Zickmund,et al.  Majority of patients with hepatitis C express physical, mental, and social difficulties with antiviral treatment , 2006, European journal of gastroenterology & hepatology.

[15]  Sanjeev Arora,et al.  Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon α‐2a (40 kDa) plus ribavirin: Impact on health‐related quality of life , 2006, Journal of gastroenterology and hepatology.

[16]  C. Treloar,et al.  The Experience of Interferon-Based Treatments for Hepatitis C Infection , 2005, Qualitative health research.

[17]  R. Hays,et al.  Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment , 2005, Hepatology.

[18]  L. Seeff,et al.  Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .

[19]  Ross D Crosby,et al.  Defining clinically meaningful change in health-related quality of life. , 2003, Journal of clinical epidemiology.

[20]  G. Norman,et al.  Interpretation of Changes in Health-related Quality of Life: The Remarkable Universality of Half a Standard Deviation , 2003, Medical care.

[21]  Dieter Häussinger,et al.  Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[22]  Kenneth Koury,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[23]  V. Coates,et al.  Diagnosed with Hepatitis C: a descriptive exploratory study. , 2001, International journal of nursing studies.

[24]  E L Murphy,et al.  Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.

[25]  W. Tierney,et al.  Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. , 1999, Journal of clinical epidemiology.

[26]  W M Tierney,et al.  Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. , 1999, Medical care.

[27]  J. M. Calvo Romero,et al.  Gastric adenocarcinoma and kidney transplantation , 1998 .

[28]  M. Liang,et al.  Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. , 1995, Journal of clinical epidemiology.

[29]  R. Groszmann,et al.  American association for the study of liver diseases , 1992 .

[30]  P. Lachenbruch.  Statistical Power Analysis for the Behavioral Sciences (2nd ed.) , 1989 .

[31]  N. Larocca,et al.  The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. , 1989, Archives of neurology.

[32]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[33]  Howard B. Lee,et al.  Foundations of Behavioral Research , 1965 .

[34]  Sanjeev Arora,et al.  Treatment of chronic hepatitis C patients with persistently normal alanine aminotransferase levels with the combination of peginterferon alpha-2a (40 kDa) plus ribavirin: impact on health-related quality of life. , 2006, Journal of gastroenterology and hepatology.

[35]  J. Emparanza,et al.  [The prevalence of hepatitis C virus infection]. , 1998, Gastroenterologia y hepatologia.

[36]  T. Spencer,et al.  AIDS Education and Training Centers fact sheet. U.S. Department of Health and Human Services Health Resources and Services Administration. , 1995, Dental assistant.